ZEVRA THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on signature page)
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitute and appoint Neil F. McFarlane and R. LaDuane Clifton, and each of them (with full power to each of them to act alone), as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Neil F. McFarlane | ||
| Neil F. McFarlane | President and Chief Executive Officer (Principal Executive Officer) | April 1, 2024 |
| /s/ R. LaDuane Clifton | ||
| R. LaDuane Clifton, MBA, CPA | Chief Financial Officer, Secretary and Treasurer (Principal Financial Officer) | April 1, 2024 |
| /s/ Timothy J. Sangiovanni | ||
| Timothy J. Sangiovanni, CPA | Senior Vice President, Corporate Controller (Principal Accounting Officer) | April 1, 2024 |
| /s/ Thomas D. Anderson | ||
| Thomas D. Anderson | Director | April 1, 2024 |
| /s/ John B. Bode | ||
| John B. Bode | Director | April 1, 2024 |
| /s/ Douglas W. Calder | ||
| Douglas W. Calder | Director | April 1, 2024 |
| /s/Wendy Dixon | ||
| Wendy Dixon | Director | April 1, 2024 |
| /s/ Tamara A. Favorito | ||
| Tamara A. Favorito | Director | April 1, 2024 |
| /s/ Alvin Shih | ||
| Alvin Shih | Director | April 1, 2024 |
| /s/ Corey Watton | ||
| Corey Watton | Director | April 1, 2024 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.